You engage KOLs and investigators in the field. ClinicaLister collapses pre-call prep from hours to minutes and maps the investigators, trials, and evidence across your territory — so every scientific exchange is prepared and citation-backed.
The highest-leverage things ClinicaLister does for a medical science liaison.
Every recurring activity, mapped to what ClinicaLister does — on which surface (the App, the MCP graph, or both), the time it saves, and how confident that claim is.
| Activity | What ClinicaLister does | Surface | Time saved | Confidence |
|---|---|---|---|---|
| Pre-call planning for a KOL meeting | Pull a KOL's trials, publications, disease context, and safety and label facts into one sourced brief before the meeting. | Both | ~2h → minutes | High |
| Trial-site & investigator ID in a territory | Map every trial site and investigator across your territory from real trial-contact records, with drill-down to each facility. | Both | territory site/PI list in minutes | High |
| KOL identification & tiering | Rank thought leaders by trial involvement and publication output, and flag the ones sitting on multiple competing trials. | Both | directional tiering in minutes | Medium |
| Respond to unsolicited medical questions | Ground an accurate answer in official drug labels, trial endpoints, and safety data — the response stays MSL-authored. | Both | fact-assembly in minutes (answer MSL-authored) | High |
| Safety / label awareness for discussions | A per-drug safety snapshot pulls together label warnings, adverse-event severity, and disproportionality signals in one view. | Both | per-drug safety snapshot in minutes | High |
| Literature currency / publication landscape | Map where the evidence concentrates across a therapeutic area, with journal tiers, so there's no manual literature sweep. | MCP | evidence map + journal tiers, no PubMed sweep | High |
| Endpoint fluency across the competitive set | Compare primary and secondary endpoints side by side across the whole therapeutic area. | MCP | side-by-side endpoints in minutes | High |
| Competitive scientific tracking | See the full pipeline for an indication by sponsor, without hopping between portals. | Both | landscape without portal-hopping | High |
| Congress / conference coverage | Assemble the trial, publication, and investigator picture and scan newly posted trials for faster prep and debrief. | Both | faster prep/debrief — no session feed | Medium |
| Investigator-initiated-trial (IIT) scoping | Find investigators with a relevant trial track record in your indication and territory. | Both | candidate PI shortlist in minutes | Medium |
| Advisory-board support (selection + briefing) | Identify high-activity thought leaders and assemble the evidence briefing behind them. | Both | advisor shortlist + brief faster | Medium |
| Territory / account scientific planning | Map the trials, sites, and investigators across your territory with geographic filters. | Both | territory landscape in minutes | Medium |
| Capture & report field medical insights | Not supported — there's no field-interaction or insight-capture layer. | — | — | n/a |
Straight answers on where ClinicaLister stops today — so there are no surprises.
No MSL CRM or field-interaction layer. There are no call notes, KOL engagement history, sentiment, or the insight-capture-and-reporting workflow that sits at the core of the MSL job.
No approved scientific content. It assembles the facts, but there are no slide decks, medical-information response documents, or compliance-cleared assets — you author those elsewhere.
KOL data is registry-published, not a curated database. Thought leaders are inferred from trial contacts and publication output; there's no curated influence, affiliation, or network database, and contact detail is limited to what registries publish.
No territory or account-planning tooling. Geography can be filtered and mapped, but there's no account plan, engagement-target management, or KPI tracking.
No live congress or abstract feed. Sources are public and not real-time, and safety outputs are statistical candidates, not confirmed causal findings.
No standalone MSL page today. The role is a proposed persona folded into Medical Affairs Lead (/who-we-serve/medical-affairs) for now, even though the platform already has a dedicated set of MSL workflows.
One sourced brief per KOL in minutes — their trials, publications, endpoints, and safety and label context — plus a map of the investigators and evidence in your territory, so you walk in prepared and credible.